"10.1371_journal.pone.0104814","plos one","2014-08-14T00:00:00Z","Inger Øynebråten; Jorma Hinkula; Agnete B Fredriksen; Bjarne Bogen","Dept. of Immunology, University of Oslo and Oslo University Hospital – Rikshospitalet, Oslo, Norway; Centre for Immune Regulation, University of Oslo, Oslo, Norway; Division of Molecular Virology, Dept. of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; KG Jebsen Centre for research on Influenza Vaccines, University of Oslo, Oslo, Norway","Conceived and designed the experiments: IØ JH ABF BB. Performed the experiments: IØ JH ABF. Analyzed the data: IØ JH ABF BB. Contributed to the writing of the manuscript: IØ BB.","BB and ABF are inventors on patent applications filed on the vaccine molecules by the TTO offices of the University of Oslo and Oslo University Hospital, according to institutional rules (US 2004/0253238 A1: Modified Antibody; 61538,186: Vaccibodies targeting to cross-presenting dendritic cells; 10167291.3-1222: Homodimeric protein constructs). BB is head of the Scientific panel, and ABF is CSO of the Vaccibody company. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2014","08","Inger Øynebråten","IØ",4,TRUE,4,3,4,NA,TRUE,TRUE,FALSE,0,NA,FALSE
